Here's the thing about the share price... Magicbox, you keep harping on the timing of results... the more important piece is that Antibe is starting to generate the recognition it deserves... if the phase IIb results demonstrate what we expect them to, ATE can get on with partnering the lead drug candidate and then using the upfront payment to leverage our platform technology and advance the other candidates through the pipeline... I wish I had known about our story a year ago, I was late to the game at 50 cents... but better late than never; and considering that the share price could be multiples of the current price by the end of this year, many other investors are probably coming to the same conclusion that I did, just at 60, 65c+++ Next week or next month, whoever pays 75 cents to buy there shares is still going to be nearly as happy as me when the share price is $3, $4 etc. :)
Just some big picture food for thought.
Cpac